BridgeMD
Tests treatment safety and results for Glaucoma
Official title Efficacy and Safety of iStent in Reducing Intraocular Pressure in Open-angle Glaucoma
ClinicalTrials.gov ID: NCT07354009
What this study is testing
- What it's testing
- To evaluate the efficacy and safety of istent inject W in reducing intraocular pressure in Chinese adult patients with open-angle glaucoma complicated with cataract.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 90. Healthy volunteers may be eligible.
You may be able to join if
- Gender is not limited. Applicants must be 18 years old or above;
- Study patients whose eyes were diagnosed with open-angle glaucoma;
- The study eye was diagnosed with cataract and met the conditions for phacoemulsification, with the best corrected visual acuity ≤0.7(patients with...
- Angular endoscopy confirmed that the opening Angle of the study eye was normal (defined as Shaffer grade ≥3, and there was no peripheral anterior...
- The patient is capable and willing to provide written informed consent and participate in the regular postoperative follow-up as required.
You likely can't join if
- Patients with angle-closure, pigmentary or pseudo-exfoliative glaucoma;
- Patients with traumatic, malignant uveitis, neovascular or glaucoma related to vascular diseases;
- Suffering from severe diabetic retinopathy, retinal detachment, central retinal vein or artery occlusion, retinal chromosomal degeneration, macular...
- Patients with identifiable congenital abnormalities of the anterior chamber Angle;
- Having clinically significant corneal dystrophy, active inflammation or having undergone surgery that may interfere with the reliability of...
- Patients with retrobulbar tumors, thyroid eye disease, cavernous sinus fistula, Sturge-Weber syndrome or any other disease that may cause elevated...
See the full eligibility criteria
- Gender is not limited. Applicants must be 18 years old or above;
- Study patients whose eyes were diagnosed with open-angle glaucoma;
- The study eye was diagnosed with cataract and met the conditions for phacoemulsification, with the best corrected visual acuity ≤0.7(patients with the best corrected visual acuity \>0.7 who were determined by the...
- Angular endoscopy confirmed that the opening Angle of the study eye was normal (defined as Shaffer grade ≥3, and there was no peripheral anterior iris adhesion, polycythemia or other abnormal conditions that might...
- The patient is capable and willing to provide written informed consent and participate in the regular postoperative follow-up as required.
- Patients with angle-closure, pigmentary or pseudo-exfoliative glaucoma;
- Patients with traumatic, malignant uveitis, neovascular or glaucoma related to vascular diseases;
- Suffering from severe diabetic retinopathy, retinal detachment, central retinal vein or artery occlusion, retinal chromosomal degeneration, macular degeneration, macular edema, and determined by researchers to...
- Patients with identifiable congenital abnormalities of the anterior chamber Angle;
- Having clinically significant corneal dystrophy, active inflammation or having undergone surgery that may interfere with the reliability of intraocular pressure measurement;
- Patients with retrobulbar tumors, thyroid eye disease, cavernous sinus fistula, Sturge-Weber syndrome or any other disease that may cause elevated venous pressure in the outer sclera;
- Suffering from eye or systemic diseases that affect surgical safety or subsequent examinations;
- Pregnant women, lactating women, women of childbearing age who plan to get pregnant during the research period or are unable to take effective contraceptive measures;
- Failure to follow the doctor's advice;
- Other circumstances where the researcher determines that the patient is not suitable for inclusion
The study team makes the final eligibility decision.
Where it's taking place
- Hangzhou, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 90 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hangzhou, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.